<DOC>
	<DOCNO>NCT03039920</DOCNO>
	<brief_summary>Electronic cigarette propose bridge smoking cessation . In study examine effect aortic elasticity , glycocalyx integrity , exhale carbon monoxide ( CO ) concentration , acutely 1 month use .</brief_summary>
	<brief_title>The Effects Electronic Cigarette Smoking Arterial Wall Endothelial Glycocalyx Properties Smokers</brief_title>
	<detailed_description>Two smoker group match age sex assess : 1. group 30 current smoker diagnose cardiovascular disease control group chronic phase 2. group 30 current smoker diagnose cardiovascular disease use electronic cigarette nicotine 1 month In acute phase 60 smoker undergo `` sham '' smoke 7 minute . Afterwards 30 60 smoker randomize smoke either normal cigarette electronic cigarette nicotine 40 minute washout period subject cross alternate mode smoking ( electronic nicotine normal cigarette respectively ) . The remain 30 smoker randomize smoke either normal cigarette electronic cigarette without nicotine 40 minute washout period subject cross alternate mode smoking ( electronic without nicotine normal cigarette respectively . After completion acute phase 60 smoker start use electronic cigarette one month . In acute phase , measurement perform baseline , sham smoke smoke normal electronic cigarette ( without nicotine ) . The chronic phase measurement perform 1 month use electronic cigarette nicotine . Thirty current smoker similar age sex serve control measurement baseline 1 month baseline assessment . The nicotine concentration electronic cigarette fluid use phase 12 mg/dL , participant allow use cigarette preference acute phase . In phase assess ) aortic pulse wavw velocity ( PWV ) augmentation index ( AIx ) Arteriograph Complior ; b ) perfusion boundary region sublingual arterial microvessels use Sideview , Darkfield imaging ( Microscan , Glycocheck ) ; c ) exhale carbon monoxide ( CO ) level ( part per million -ppm ) smoking status marker ; ) vital sign ; e ) electrocardiogram ; f ) plasma level C- reactive protein ( CRP ) , transform growth factor-b ( TGF-b ) , lipoprotein associate phospholipase A2 ( LP- LPA2 ) , tumor necrosis factor- α ( TNF-α ) , interleukins 6 10 ( IL-6 -10 ) , procollagen propeptide type III ( PIIINP ) , matrix metalloproteinase 2 9 ( MMP-2 -9 ) , macrophage-colony stimulating factor ( MCSF ) , malondialdehyde ( MDA ) protein carbonyl ( PCs ) .</detailed_description>
	<criteria>Active conventional cigarette smoker Health condition adversely affect smoking , history presence cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>